{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T07:48:32Z","timestamp":1721375312576},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T00:00:00Z","timestamp":1553817600000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.1093\/jac\/dkz037","type":"journal-article","created":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T23:24:15Z","timestamp":1550445855000},"page":"ii3-ii8","source":"Crossref","is-referenced-by-count":3,"title":["Standards of CARE: what is considered \u2018best practice\u2019 for the management of invasive fungal infections? A haematologist\u2019s and a mycologist\u2019s perspective"],"prefix":"10.1093","volume":"74","author":[{"given":"Katrien","family":"Lagrou","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium"},{"name":"Clinical Department of Laboratory Medicine and National Reference Centre for Mycosis, UZ Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael F","family":"Duarte","sequence":"additional","affiliation":[{"name":"Servicio de Hematolog\u00eda y Hemoterapia, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium"},{"name":"Clinical Department of Haematology, UZ Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,3,23]]},"reference":[{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B1","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3324\/haematol.2009.012054","article-title":"Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study","volume":"95","author":"Pagano","year":"2010","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B2","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/652768","article-title":"Factors associated with mortality in transplant patients with invasive aspergillosis","volume":"50","author":"Baddley","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B3"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B4","first-page":"986","article-title":"Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)","volume":"91","author":"Chamilos","year":"2006","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/myc.12081","article-title":"Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study","volume":"56","author":"Lewis","year":"2013","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1749-6632.2012.06829.x","article-title":"Risk stratification for invasive aspergillosis in immunocompromised patients","volume":"1272","author":"Herbrecht","year":"2012","journal-title":"Ann NY Acad Sci"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B8","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation\u2014a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B11","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1200\/JCO.2007.12.3851","article-title":"Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis","volume":"25","author":"Robenshtok","year":"2007","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B12","first-page":"3221","article-title":"European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia","volume":"73","author":"Maertens","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B13","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/586739","article-title":"Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial","volume":"46","author":"Rijnders","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B14","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation","volume":"39","author":"van Burik","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B15","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/jac\/dkx133","article-title":"Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia","volume":"72","author":"Cornely","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2141.2011.08838.x","article-title":"Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation","volume":"155","author":"Marks","year":"2011","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B17","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/myc.12103","article-title":"Volume dependency for culture of fungi from respiratory secretions and increased sensitivity of Aspergillus quantitative PCR","volume":"57","author":"Fraczek","year":"2014","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B19","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1128\/JCM.00263-17","article-title":"Validation of a new web application for identification of fungi by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry","volume":"55","author":"Normand","year":"2017","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1128\/JCM.02913-15","article-title":"Diagnostic performance of galactomannan antigen testing in cerebrospinal fluid","volume":"54","author":"Chong","year":"2016","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B21","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/514349","article-title":"Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay","volume":"44","author":"Maertens","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B22","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1378\/chest.10-0488","article-title":"Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review","volume":"138","author":"Guo","year":"2010","journal-title":"Chest"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jac\/dkm217","article-title":"Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients","volume":"60","author":"Oshima","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1200\/JCO.2009.21.8032","article-title":"Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility study","volume":"28","author":"Girmenia","year":"2010","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B26","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/597395","article-title":"Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B27","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1016\/j.ijid.2011.01.011","article-title":"Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study","volume":"15","author":"Tan","year":"2011","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B28","doi-asserted-by":"crossref","first-page":"257.","DOI":"10.1056\/NEJM197507312930513","article-title":"Nomogram for Bayes theorem","volume":"293","author":"Fagan","year":"1975","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B29","first-page":"557","article-title":"Selection and interpretation of diagnostic tests and procedures. Principles and applications","volume":"94","author":"Griner","year":"1981","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B30","doi-asserted-by":"crossref","first-page":"S381","DOI":"10.1086\/430920","article-title":"Design issues in studies evaluating diagnostic tests for aspergillosis","volume":"41","author":"Marr","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B31","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1086\/651161","article-title":"Galactomannan detection and diagnosis of invasive aspergillosis","volume":"50","author":"Donnelly","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B32","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/cid\/ciu673","article-title":"Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis","volume":"59","author":"Duarte","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B33","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/bmt.2016.279","article-title":"Serum galactomannan surveillance may be safely withdrawn from antifungal management of hematology patients on effective antimold prophylaxis: a pilot single-center study","volume":"52","author":"Duarte","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B34","doi-asserted-by":"crossref","first-page":"1000.e1","DOI":"10.1016\/j.cmi.2017.05.006","article-title":"The misleading effect of serum galactomannan testing in high-risk haematology patients receiving prophylaxis with micafungin","volume":"23","author":"Vena","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B35","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B36","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciq206","article-title":"\u03b2-d-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis","volume":"52","author":"Karageorgopoulos","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B37","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/jac\/dkw156","article-title":"ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Alanio","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B38","doi-asserted-by":"crossref","first-page":"i29","DOI":"10.1093\/jac\/dkx031","article-title":"Clinical considerations in the early treatment of invasive mould infections and disease","volume":"72","author":"Mercier","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2217\/fmb.15.111","article-title":"T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis","volume":"11","author":"Pfaller","year":"2016","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B40","first-page":"402","article-title":"Determining the analytical specificity of PCR-based assays for the diagnosis of IA: what is Aspergillus?","volume":"55","author":"Morton","year":"2017","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B41","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/JCM.00905-15","article-title":"Clinical performance of Aspergillus PCR for testing serum and plasma: a study by the European Aspergillus PCR Initiative","volume":"53","author":"White","year":"2015","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B42","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1128\/JCM.00744-13","article-title":"Development and evaluation of a calibrator material for nucleic acid-based assays for diagnosing aspergillosis","volume":"51","author":"Lyon","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B43","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1128\/JCM.05316-11","article-title":"Evaluation of Aspergillus PCR protocols for testing serum specimens","volume":"49","author":"White","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B44","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1128\/JCM.01466-10","article-title":"Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens","volume":"48","author":"White","year":"2010","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B45","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.cmi.2016.06.021","article-title":"Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1, 3-\u03b2-d-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study","volume":"22","author":"Boch","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B47","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomized-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B48","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: a randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B50","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1093\/jac\/dkx319","article-title":"Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus","volume":"72","author":"Arendrup","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B51","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/jac\/dkw323","article-title":"PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay\u00ae in 201 patients with haematological disease suspected for invasive aspergillosis","volume":"71","author":"Chong","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B52","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3389\/fmicb.2016.01164","article-title":"Direct molecular diagnosis of Aspergillosis and CYP51A profiling from respiratory samples of French patients","volume":"7","author":"Zhao","year":"2016","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t2019032903094165200_dkz037-B53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/10428194.2010.542600","article-title":"Design issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies","volume":"52","author":"Morrissey","year":"2011","journal-title":"Leuk Lymphoma"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/Supplement_2\/ii3\/28223633\/dkz037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T03:10:03Z","timestamp":1553829003000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/Supplement_2\/ii3\/5420183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":53,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2019,3,23]]},"published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkz037","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3]]},"published":{"date-parts":[[2019,3,1]]}}}